ChEMBL logo

ChEMBL

spacer
ChEMBL Statistics
  Loading Statistics...
spacer

Compound Report Card

Compound Name and Classification

Compound ID CHEMBL403664
CHEMBL403664
Compound Name BLEOMYCIN
ChEMBL Synonyms BLEOMYCIN | Bleomycin sulfate | BLEO-KYOWA | Blenoxane
Max Phase 4 (Approved)
Trade Names BLEOMYCIN SULFATE | Blenoxane | BLEO-KYOWA
Molecular Formula C55H84N17O21S3+

Additional synonyms for CHEMBL403664 found using NCI Chemical Identifier Resolver

Compound Representations

Molfile Download MolFile
Canonical SMILES C[C@@H](O)[C@H](NC(=O)[C@@H](C)[C@H](O)[C@@H](C)NC(=O)[C@@H] ...
Download SMILES
Standard InChI InChI=1S/C55H83N17O21S3/c1-20-33(69-46(72-44(20)58)25(12-31( ...
Download InChI
Standard InChI Key OYVAGSVQBOHSSS-UAPAGMARSA-O

Sources

  • British National Formulary
  • Orange Book
  • Sanger Institute Genomics of Drug Sensitivity in Cancer
  • Scientific Literature
  • USP Dictionary of USAN and International Drug Names
  • WHO Anatomical Therapeutic Chemical Classification

Alternate Forms of Compound in ChEMBL


CHEMBL403664

Molecule Features

CHEMBL403664 compound icon
Drug Type:Natural Product-derived Rule of Five:N First In Class:N Chirality:Single Stereoisomer Prodrug:N Oral:N Parenteral:Y Topical:N Black Box:N Availability Type:Prescription-only

Mechanism of Action

Mechanism of Action ChEMBL Target References
DNA inhibitor DNA DailyMed

Indications

MESH Heading MESH ID EFO ID EFO Term Max phase for indication References
Carcinoma, Squamous CellD002294EFO:0000707squamous cell carcinoma4DailyMed
DailyMed
Multiple MyelomaD009101EFO:0001378multiple myeloma2ClinicalTrials
Head and Neck NeoplasmsD006258EFO:0006859head and neck malignant neoplasia3ClinicalTrials
LymphomaD008223EFO:0000574lymphoma3ClinicalTrials
Pancreatic NeoplasmsD010190EFO:0002618pancreatic carcinoma1ClinicalTrials
Rectal NeoplasmsD012004EFO:1000657rectum cancer2ClinicalTrials
NeoplasmsD009369EFO:0000616neoplasm4ATC
NeoplasmsD009369EFO:0000311cancer3ClinicalTrials
Testicular NeoplasmsD013736EFO:0004281testicular neoplasm3ClinicalTrials
Hodgkin DiseaseD006689EFO:0000183Hodgkins lymphoma3ClinicalTrials
Lymphoma, AIDS-RelatedD016483EFO:1001365Lymphoma, AIDS-Related2ClinicalTrials
Lymphoma, Large B-Cell, DiffuseD016403EFO:0000403diffuse large B-cell lymphoma3ClinicalTrials
GliomaD005910EFO:0000326central nervous system cancer2ClinicalTrials
Neoplasms, Germ Cell and EmbryonalD009373EFO:0000514germ cell tumor3ClinicalTrials
MelanomaD008545EFO:0000389cutaneous melanoma1ClinicalTrials
Pericardial EffusionD010490EFO:0007298hemopericardium3ClinicalTrials
Pleural Effusion, MalignantD0160664DailyMed
DailyMed
HIV InfectionsD015658EFO:0000180HIV-1 infection3ClinicalTrials
Uterine Cervical NeoplasmsD002583EFO:0001061cervical carcinoma3ClinicalTrials

Clinical Data

ClinicalTrials.gov BLEOMYCIN
The Cochrane Collaboration BLEOMYCIN

Compound Bioactivity Summary

Compound Assay Summary

Compound Target Summary

Calculated Compound Parent Properties

Mol. Weight Mol. Weight Monoisotopic ALogP #Rotatable Bonds Polar Surface Area Molecular Species
1415.6 1414.5184 - - - -


HBA HBD #Ro5 Violations HBA (Lipinski) HBD (Lipinski) #Ro5 Violations (Lipinski)
- - - - - -


ACD Acidic pKa ACD Basic pKa ACD LogP ACD LogD pH7.4 Aromatic Rings Heavy Atoms QED Weighted
- - - - - - -0

Structural Alerts

There are no structural alerts for CHEMBL403664

Compound Cross References

ATC L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 - ANTINEOPLASTIC AGENTS
L01D - CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
L01DC - Other cytotoxic antibiotics
L01DC01 - bleomycin

ChemSpider ChemSpider:OYVAGSVQBOHSSS-UAPAGMARSA-O
DailyMed bleomycin sulfate
Wikipedia Bleomycin

UniChem Cross References

View the UniChem Connectivity matches for CHEMBL403664



ACToR 11056-06-7
Atlas bleomycin
ChEBI 3139
EPA CompTox Dashboard DTXSID20872327
KEGG Ligand C06854
Metabolights MTBLC3139
Nikkaji J25.633A
PubChem 5460769
SureChEMBL SCHEMBL134155

UniChem REST Service Call:
https://www.ebi.ac.uk/unichem/rest/verbose_inchikey/OYVAGSVQBOHSSS-UAPAGMARSA-O spacer
spacer